CIFI
DEAD

Serial Number

90294501

Owner

Arima Genomics Inc.

Attorney

Samantha C. Markley

Filing Date

Nov 2, 2020

Add to watchlist:

No watchlists yet
View on USPTO

CIFI Trademark

Serial Number: 90294501

CIFI is a trademark filed by Arima Genomics Inc. on November 2, 2020. The trademark is classified under Class 1 (Chemicals), Class 5 (Pharmaceuticals), Class 42 (Computer & Scientific), Class 44 (Medical Services). The application is currently no longer active.

Owner Contact Info

Arima Genomics Inc. (2 trademarks)

6404 Nancy Ridge Dr
San Diego, CA 92121

Entity Type: 03

Trademark Details

Filing Date

November 2, 2020

Registration Date

Not Registered

Published for Opposition

May 25, 2021

Goods & Services

Diagnostic preparations for medical purposes; diagnostic preparations for humans for medical purposes; diagnostic preparations for medical and veterinary purposes, namely, diagnostic preparations, for sample preparation, modification and manipulation of cells and for marking, separating, isolating, purifying, duplicating, sequencing and/or for the analysis of biopolymers in the nature of nucleic acids, proteins, macromolecules and biologically active substances in the nature of reagents, enzymes and buffer solutions for nucleic acid purification, enrichment, amplification and sequencing; chemical, biochemical and biotechnological preparations for medical and veterinary purposes, namely, diagnostic reagents, enzymes and diagnostic reagents in the nature of buffer solutions for sample preparation, modification and manipulation of cells and for marking, separating, isolating, purifying, duplicating, sequencing and/or for the analysis of biopolymers in the nature of nucleic acids, proteins, macromolecules and biologically active substances, in the nature of reagents, enzymes and buffer solutions for nucleic acid purification, enrichment, amplification and sequencing; kits containing preparations for medical and veterinary diagnostic purposes primarily consisting of diagnostic preparations for sample preparation, modification and manipulation of cells and for marking, separating, isolating, purifying, duplicating, sequencing and/or for the analysis of biopolymers, in the nature of nucleic acids, proteins, macromolecules and biologically active substances, in the nature of reagents, enzymes and buffer solutions for nucleic acid purification, enrichment, amplification and sequencing

Reagents for scientific and research use; Enzymes for scientific and research use; Kits for scientific and research use, namely, kits for molecular biology and cell biology applications comprising enzymes for scientific and research purposes; Reagents for scientific and research use in the field of molecular biology and cell biology applications; Enzymes for scientific and research use in the field of molecular biology and cell biology applications; Reagents for scientific and research use for amplification of DNA; Reagent kits for amplification of DNA comprising at least one of enzymes, buffers, and nucleic acids for use in biotechnology fields for scientific and research purposes; Reagents for scientific and research use for use in nucleic acid sequencing for scientific and research purposes; Kits for use in nucleic acid sequencing, namely, kits for molecular biology and cell biology applications comprised of at least one of enzymes, buffers, and nucleic acids for scientific and research purposes; kits for molecular biological research, namely, sequencing kits for scientific and research use said kits primarily comprising enzymes, reagents, and vectors

Gene analysis and sequencing as well as DNA analysis and sequencing for medical diagnostic purposes; gene analysis and sequencing as well as DNA analysis and sequencing for use in cancer diagnosis and treatment

Scientific research services, namely, gene analysis and sequencing as well as DNA analysis and sequencing; scientific research services, namely, preparation of materials for gene analysis and sequencing as well as DNA analysis and sequencing

Filing History

ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Aug 22, 2022 MAB6
ABANDONMENT - NO USE STATEMENT FILED
Aug 22, 2022 ABN6
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Nov 10, 2021 EXRA
SOU EXTENSION 1 GRANTED
Nov 8, 2021 EX1G
SOU EXTENSION 1 FILED
Nov 8, 2021 EXT1
SOU TEAS EXTENSION RECEIVED
Nov 8, 2021 EEXT
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Jul 20, 2021 NOAM
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
May 25, 2021 NPUB
PUBLISHED FOR OPPOSITION
May 25, 2021 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
May 5, 2021 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Apr 15, 2021 CNSA
EXAMINER'S AMENDMENT ENTERED
Apr 15, 2021 XAEC
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Apr 15, 2021 GNEN
EXAMINERS AMENDMENT E-MAILED
Apr 15, 2021 GNEA
EXAMINERS AMENDMENT -WRITTEN
Apr 15, 2021 CNEA
TEAS/EMAIL CORRESPONDENCE ENTERED
Apr 14, 2021 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Apr 13, 2021 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Apr 13, 2021 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Apr 5, 2021 GNRN
NON-FINAL ACTION E-MAILED
Apr 5, 2021 GNRT
NON-FINAL ACTION WRITTEN
Apr 5, 2021 CNRT
ASSIGNED TO EXAMINER
Apr 5, 2021 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Dec 30, 2020 NWOS
NEW APPLICATION ENTERED
Nov 5, 2020 NWAP